PHGE
BiomX Inc.
Key Financials
Operating Income
$-41466000
↑ 6.9%
Net Income
$-36199000
↓ 104.2%
EPS (Diluted)
$22.19
↑ 560.4%
Total Assets
$5.8M
↓ 86.6%
Total Liabilities
$871011.00
↑ 2024.4%
Shareholders' Equity
$-1302000.00
↓ 105.4%
Cash & Equivalents
$4.4M
↓ 74.1%
Long-term Debt
$11.2M
↓ 25.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 7/2/2026 | View on SEC |
| S-8 | 6/30/2026 | View on SEC |
| S-1 | 6/29/2026 | View on SEC |
| 8-K | 6/26/2026 | View on SEC |
| DEFA14A | 6/22/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| SCHEDULE 13D/A | 6/16/2026 | View on SEC |
| 424B5 | 6/16/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| 8-K/A | 6/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PHGE |
| Company Name | BiomX Inc. |
| CIK | 1739174 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 972 545610935 |